APP and Alzheimer disease: The results demonstrated that the mRNA and protein expression of OPTN was downregulated in the cerebral cortex and hippocampus of 9-month-old APP/PS1 Tg mice compared to that of WT mice (Fig. 1E–G), which is consistent with the transcriptomic sequencing data from AD patients (Fig. 1A–D).